Firmicutes spores
Cell therapyexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started May 1, 2015 (NCT02437500)
Timeline
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ser-109
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03183128 | Phase 3 | Jun 1, 2017 | Seres Therapeutics |
| NCT03183141 | Phase 3 | Jun 1, 2017 | Seres Therapeutics |
| NCT02437487 | Phase 2 | May 1, 2015 | INC Research, Seres Therapeutics |
| NCT02437500 | N/A | May 1, 2015 | INC Research, Seres Therapeutics |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Seres Therapeutics | For profit | 4 | 4 | 3 | 2015 |
| INC Research | For profit | 2 | 0 | 2 | 2015 |
2 organizations
Page 1 / 1